Skip to main content

Adherence, Patient

1
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Bayer
BayerLEVERKUSEN, Germany
1 program
1
Adherence to topical standard therapy assessedPhase 41 trial
Active Trials
NCT04016025Completed80Est. Apr 2022
Gilead Sciences
Gilead SciencesFOSTER CITY, CA
2 programs
PrEP Care Anywhere ServicesN/A
PrEP Care Anywhere ServicesN/A
Kite Pharma
Kite PharmaCA - El Segundo
1 program
PrEP Care Anywhere ServicesN/A1 trial
Active Trials
NCT03442192Terminated20Est. Dec 2021

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
BayerAdherence to topical standard therapy assessed
Kite PharmaPrEP Care Anywhere Services

Clinical Trials (2)

Total enrollment: 100 patients across 2 trials

NCT04016025BayerAdherence to topical standard therapy assessed

A Clinical Study of Adherence to Methylprednisolone Aceponate in Different Carriers

Start: Dec 2020Est. completion: Apr 202280 patients
Phase 4Completed
NCT03442192Kite PharmaPrEP Care Anywhere Services

A Comparative Effectiveness Demonstration Project for Linkage and Retention in PrEP Care for Men Who Have Sex With Men

Start: Jul 2018Est. completion: Dec 202120 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.